Search research articles
Contact Us
Filters
Showing results (131-140 of 176) with videos related to
Page
of 18
Sort By:
Journal of Lipid Research
|
June 23, 2009
Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III
Doris T Chan, Gursharan K Dogra, Ashley B Irish, et al.
Metabolism: Clinical and Experimental
|
April 3, 2020
PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)
Gerald F Watts, Dick C Chan, Jing Pang, et al.
Australian Journal of General Practice
|
August 31, 2021
Implications of new clinical practice guidance on familial hypercholesterolaemia for Australian general practitioners
Tom Brett, Jan Radford, Clare Heal, et al.
Clinical Endocrinology
|
November 24, 2006
Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo
Esther M M Ooi, Gerald F Watts, Juying Ji, et al.
Diabetes Care
|
May 30, 2008
Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome
Esther M M Ooi, Gerald F Watts, Dick C Chan, et al.
Diabetes Care
|
August 5, 2009
Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndrome
Dick C Chan, Gerald F Watts, Esther M M Ooi, et al.
Asia Pacific Journal of Clinical Nutrition
|
November 29, 2007
Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome
Esther M M Ooi, Gerald F Watts, P Hugh R Barrett, et al.
Clinical Science (London, England : 1979)
|
May 17, 2006
Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome
Gerald F Watts, Juying Ji, Dick C Chan, et al.
Journal of the American Heart Association
|
March 17, 2020
Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease
Jonathan Golledge, Sophie Rowbotham, Ramesh Velu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 5, 2016
ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia
Dick C Chan, Jing Pang, P Hugh R Barrett, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 176) with videos related to
Sort By:
Page
of 18
Journal of Lipid Research
|
June 23, 2009
Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III
Doris T Chan, Gursharan K Dogra, Ashley B Irish, et al.
Metabolism: Clinical and Experimental
|
April 3, 2020
PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)
Gerald F Watts, Dick C Chan, Jing Pang, et al.
Australian Journal of General Practice
|
August 31, 2021
Implications of new clinical practice guidance on familial hypercholesterolaemia for Australian general practitioners
Tom Brett, Jan Radford, Clare Heal, et al.
Clinical Endocrinology
|
November 24, 2006
Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo
Esther M M Ooi, Gerald F Watts, Juying Ji, et al.
Diabetes Care
|
May 30, 2008
Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome
Esther M M Ooi, Gerald F Watts, Dick C Chan, et al.
Diabetes Care
|
August 5, 2009
Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndrome
Dick C Chan, Gerald F Watts, Esther M M Ooi, et al.
Asia Pacific Journal of Clinical Nutrition
|
November 29, 2007
Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome
Esther M M Ooi, Gerald F Watts, P Hugh R Barrett, et al.
Clinical Science (London, England : 1979)
|
May 17, 2006
Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome
Gerald F Watts, Juying Ji, Dick C Chan, et al.
Journal of the American Heart Association
|
March 17, 2020
Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease
Jonathan Golledge, Sophie Rowbotham, Ramesh Velu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 5, 2016
ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia
Dick C Chan, Jing Pang, P Hugh R Barrett, et al.
Page
of 18